ZIARCO
Ziarco, Inc. develops therapeutic agents for treating inflammatory and allergic diseases. The company was founded in 2012 and is based in Palo Alto, California.
ZIARCO
Industry:
Biotechnology Medical Therapeutics
Founded:
2012-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.ziarcopharma.com
Total Employee:
251+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
43.49 M USD
Technology used in webpage:
SPF Google Maps Microsoft Azure DNS GStatic Google Static Content Google Maps API Proofpoint Akamai DNS Fasthosts
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Lipid Therapeutics
Novel therapies for inflammatory diseases of the digestive system
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series B - Ziarco
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series B - Ziarco
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - Ziarco
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Ziarco
Amgen Ventures
Amgen Ventures investment in Series B - Ziarco
Innovate UK
Innovate UK investment in Grant - Ziarco
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Ziarco
